MoneyWorks4Me

Aarti Drugs expands anti-diabetic capacity

24 Oct 2019 Evaluate

Aarti Drugs has recently expanded its anti-diabetic capacity and currently scaling up its production quantities for the same. Further, brown field CAPEX would be done in the current financial year to expand few capacities in anti-inflammatory therapeutic category.

Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..